v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenues $ 1,534 $ 940 $ 4,387 $ 2,627
Cost of Revenues 382 298 1,109 818
Gross Profit 1,152 642 3,278 1,809
Operating Expenses        
Research and development 926 296 2,677 820
Sales and marketing 847 447 2,161 1,259
General and administrative 3,521 2,326 9,890 8,796
Acquisition related costs 573 78 1,220 94
Amortization of intangibles 969 812 2,602 2,419
Total Operating Expenses 6,836 3,959 18,550 13,388
Loss from Operations (5,684) (3,317) (15,272) (11,579)
Other Income (Expense)        
Interest expense (1,190) (78) (2,053) (981)
Loss on exchange of debt for equity (27) (188)
Change in fair value of derivative liability 48
Gain on the sale of Sysorex Arabia 23
Other income/(expense) 289 518 (11)
Total Other Income (Expense) (928) (78) (1,723) (921)
Net Loss from Continuing Operations, before tax (6,612) (3,395) (16,995) (12,500)
Income tax benefit 33 35
Net Loss from Continuing Operations (6,579) (3,395) (16,960) (12,500)
Loss from Discontinued Operations, Net of Tax (1,785) (4,778)
Net Loss (6,579) (5,180) (16,960) (17,278)
Net Income/(Loss) Attributable to Non-controlling Interest 5 4 9 6
Net Loss Attributable to Stockholders of Inpixon (6,584) (5,184) (16,969) (17,284)
Deemed dividend to preferred stockholders (11,235)
Deemed dividend for triggering of warrant down round feature (1,250)
Net Loss Attributable to Common Stockholders $ (6,584) $ (5,184) $ (18,219) $ (28,519)
Net Loss Per Basic and Diluted Common Share        
Loss from continuing operations $ (0.28) $ (3.17) $ (1.46) $ (45.97)
Loss from discontinued operations (1.67) (9.25)
Net Loss Per Share - Basic and Diluted $ (0.28) $ (4.84) $ (1.46) $ (55.24)
Weighted Average Shares Outstanding        
Basic and Diluted 23,366,543 1,071,310 12,442,450 516,302

Source